GlassScriptPhysician profile
David Kountz
NPI 1679645931
$23,101.88
in general payments reported to CMS, 2019-2025
5 companies · $6,243 in 2025
The $6,243 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2021: $3,570 · 2023: $1,283 · 2024: $12K · 2025: $6,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $1,635 · Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,165.12 |
| Travel and Lodging | $1,635.40 |
| Food and Beverage | $486.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21,574.63 | 2021-2025 | |
| Pfizer INC. | $1,120.00 | 2023 | |
| Novo Nordisk INC | $229.92 | 2019 | |
| Siemens Medical Solutions USA, INC. | $162.77 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kountz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.